Hearn Jay Cho, MD, PhD
img_Hearn Jay Cho
CLINICAL PROFESSOR | Medicine, Hematology and Medical Oncology
CLINICAL PROFESSOR | Immunology & Immunotherapy
Are you a patient?
Specialties
Hematology-Oncology, Cancer (Oncology)
Multi-Disciplinary Training Area
Disease Mechanisms and Therapeutics (DMT)

MD, Weill Medical College of Cornell University

Residency, Internal Medicine, University of California Medical Center San Diego

Fellowship, Hematology & Oncology, New York Presbyterian Hospital-Weill Cornell

Certifications

American Board of Internal Medicine
Publications

Selected Publications

Correction to: Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes (Nature Genetics, (2024), 56, 9, (1878-1889), 10.1038/s41588-024-01853-0). Sheri Skerget, Daniel Penaherrera, Ajai Chari, Sundar Jagannath, David S. Siegel, Ravi Vij, Gregory Orloff, Andrzej Jakubowiak, Ruben Niesvizky, Darla Liles, Jesus Berdeja, Moshe Levy, Jeffrey Wolf, Saad Z. Usmani, Ronald Steis, Shanti Srinivas, Vivek Roy, Paula Rodríguez, Albert Oriol, Shaji Kumar, Isabel Krsnik, May Matkiwsky, Saulias Girnius, Miguel Conde, Sumeet Chandra, Robert Anderson, William Solomon, Donald Richards, Dilip Patel, Alex Menter, Hakan Kaya, Gerald Hsu, Hani Hassoun, Joan Bargay, Larry Anderson, Eugenia Abella, Madhuri Yalamachili, William Wachsman, Fabio Volterra, Adedayo Onitilo, Fredrick Min, Marie Shieh, Michael Bar, Justinian Ngaiza, Wayne Harris, Michael Sebag, Robert Robles, Kathleen Yost, Michael Grossbard, Hearn Jay Cho. Nature Genetics

Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myeloma. Darren Pan, Tarek H. Mouhieddine, Tianxiang Sheng, Weijia Fu, Erin Moshier, Joshua Richter, Samir Parekh, Sundar Jagannath, Adriana C. Rossi, Larysa J. Sanchez, Santiago Thibaud, Cesar Rodriguez, Hearn J. Cho, Shambavi Richard. Bone Marrow Transplantation

Creating Equitable and Inclusive Clinical Trials for Multiple Myeloma. Monique Hartley-Brown, Craig E. Cole, Pamela Price, Michael Andreini, George Mulligan, Anne Quinn Young, Hearn Jay Cho. Clinical Lymphoma, Myeloma and Leukemia

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Cho during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Guidepoint
  • GRAIL, Inc

Outside Employment

  • Multiple Myeloma Research Foundation (MMRF)

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.